Header

UZH-Logo

Maintenance Infos

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol


Dörge, Petra; Meissner, Barbara; Zimmermann, Martin; Moericke, Anja; Schrauder, Andre; Bourquin, Jean-Pierre; Schewe, Denis; Harbott, Jochen; Teigler-Schlegel, Andrea; Ratei, Richard; Ludwig, Wolf Dieter; Köhler, Rolf; Bartram, Claus R; Schrappe, Martin; Stanulla, Martin; Cario, Gunnar (2013). IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica, 98(3):428-432.

Abstract

IKZF1 gene deletions have been associated with a poor outcome in pediatric precursor B-cell acute lymphoblastic leukemia. To assess the prognostic relevance of IKZF1 deletions for patients treated on Berlin-Frankfurt-Munster Study Group trial ALL-BFM 2000, we screened 694 diagnostic acute lymphoblastic leukemia samples by Multiplex Ligation-Dependent Probe Amplification. Patients whose leukemic cells beared IKZF1 deletions had a lower 5-year event-free survival (0.69+/-0.05 vs. 0.85+/-0.01; p<0.0001) compared to those without, mainly due to a higher cumulative incidence of relapses (0.21+/-0.04 vs. 0.10+/-0.01; p=0.001). Although IKZF1 deletions were significantly associated with the P2RY8-CRLF2 rearrangement, their prognostic value was found independent from this association. Thus, IKZF1 deletion is an independent predictor of treatment outcome and strong candidate marker for integration in future treatment stratification strategies on ALL-BFM protocols.

Abstract

IKZF1 gene deletions have been associated with a poor outcome in pediatric precursor B-cell acute lymphoblastic leukemia. To assess the prognostic relevance of IKZF1 deletions for patients treated on Berlin-Frankfurt-Munster Study Group trial ALL-BFM 2000, we screened 694 diagnostic acute lymphoblastic leukemia samples by Multiplex Ligation-Dependent Probe Amplification. Patients whose leukemic cells beared IKZF1 deletions had a lower 5-year event-free survival (0.69+/-0.05 vs. 0.85+/-0.01; p<0.0001) compared to those without, mainly due to a higher cumulative incidence of relapses (0.21+/-0.04 vs. 0.10+/-0.01; p=0.001). Although IKZF1 deletions were significantly associated with the P2RY8-CRLF2 rearrangement, their prognostic value was found independent from this association. Thus, IKZF1 deletion is an independent predictor of treatment outcome and strong candidate marker for integration in future treatment stratification strategies on ALL-BFM protocols.

Statistics

Citations

43 citations in Web of Science®
49 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

251 downloads since deposited on 24 Jan 2013
77 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2013
Deposited On:24 Jan 2013 15:34
Last Modified:05 Aug 2017 21:28
Publisher:Ferrata Storti Foundation
ISSN:0390-6078
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.3324/haematol.2011.056135
PubMed ID:22875627

Download

Preview Icon on Download
Preview
Content: Accepted Version
Filetype: PDF
Size: 911kB
View at publisher
Preview Icon on Download
Preview
Content: Published Version
Filetype: PDF
Size: 363kB